OBJECTIVE: @entity296 related to non-specific inflammation can be detected using late @entity2287 -enhancement cardiovascular MR (LGE-CMR), which is an important prognostic indicator for @entity384 ( @entity384 ). The aims of this study were to define the prognostic factors for @entity384 with LGE-CMR, and to evaluate the impact of the prognostic factors on adverse effects. METHODS: We performed a retrospective analysis of a prospectively maintained single centre registry. We analysed the data from 76 @entity1 with @entity384 who had been admitted for @entity712 . The primary combined end point was defined as all-cause mortality and rehospitalisation. RESULTS: LGE-CMR was present in 39 @entity1 (51%), and the mean follow-up period was 813  54   days. The primary end point occurred in 20 @entity1 (5 (13.5%) @entity1 without LGE-CMR and 15 (38.5%) @entity1 with LGE-CMR, p=0.006). Sixteen of 39 @entity1 with LGE-CMR exhibited elevated high-sensitivity @entity1851 (hs-CRP >0.3   mg/dL). @entity1 with elevated hs-CRP and LGE-CMR had a significantly higher incidence of the primary end point compared with @entity1 with normal hs-CRP and LGE-CMR (62.5%; 10 @entity1 , 22.7%; 5 @entity1 , respectively, p=0.001). Elevated hs-CRP was significantly associated with the primary end point (HR: 4.04; 95% CI 1.67 to 9.76; p=0.002). After elevated hs-CRP was adjusted for known predictors of @entity384 , it was still associated with the primary end point (HR: 2.91; 95% CI 1.19 to 7.15; p=0.02). CONCLUSIONS: Among @entity1 with @entity384 , LGE-CMR and elevated hs-CRP are associated with a higher incidence of the long-term combined end point of all-cause mortality and hospitalisation. TRIAL REGISTRATION NUMBER: UMIN000001171.

MRI and serum high-sensitivity XXXX predict long-term mortality in @entity296 .

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients'] @entity296 :: ('MESH:D009202', 'Disease') :: ['Myocardial fibrosis'] @entity712 :: ('MESH:D006333', 'Disease') :: ['acute heart failure'] @entity384 :: ('MESH:D002311', 'Disease') :: ['DCM', 'dilated cardiomyopathy'] @entity2287 :: ('MESH:D005682', 'Chemical') :: ['gadolinium'] @entity1851 :: ('1401', 'Gene') :: ['C reactive protein']
@entity1851 :: (1401,Gene) :: ['C reactive protein']
